Well, the US, despite everything, has a Covid-19 booster that is not an mRNA vaccine. On Oct. 18, the U. S. Food and Drug Administration (FDA)The U. S. Food and Drug Administration (FDA) extended the Emergency Use Authorization (EUA) for Novavax’s adjuvanted Covid-19 vaccine (NVX-CoV2373) now comes with a booster first dose for those 18 and older. On the same day, the director of the Centers for Disease Control and Prevention (CDC), Rochelle Walensky, MD, signed a resolution note. “authorizing monovalent Novavax Covid-19 recalls for adults. ” So did this progression attract as much attention as mRNA boosters from Pfizer-BioNTech and Moderna Covid-19 when they first got such extensions from the US last year?Not exactly.
In fact, @HarlotKnight, whose Twitter profile includes the description “journalist in a grunge group,” claimed in a tweet that a local pharmacy wasn’t even aware of the CDC’s updated rules for the Novavax Covid-19 vaccine:
Hmm, does this sound like a “black hole Sun” to talk about significant change?I wonder how many other people know Olivia Wilde’s special bandage better than the new Novavax Covid-19 booster. Shouldn’t the availability of Novavax Covid-19?Will the vaccine as a booster be a bigger problem?After all, the Novavax booster offers an option for those who are more comfortable with the generation that has been used for years for other vaccines, such as hepatitis and pertussis vaccines. Also, the Novavax Covid-19 vaccine is less difficult to buy and ship than Covid-19 mRNA vaccines, as I covered for Forbes in July when Nuvaxovid first won an FDA EUA, so it’s fine to use as the number one series. Again, while Pfizer-BioNTech and the Moderna vaccines consist of messenger RNA (mRNA) that serves as a blueprint for their cells to produce the spike proteins that studd the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Novavax Covid-19 vaccine the true spike proteins themselves.
Having more possible selections overall tends to be a smart thing to do because a salad bar that only contains iceberg lettuce or a single-flavor ice cream shop probably wouldn’t work as well. “Yes, don’t bother reading the menu, because you’re eating chicken. “In the case of Covid-19 boosters at this time, additional screening would possibly be necessary. This can also give the U. S. withdrawal program the U. S. withdrawal program. UUmuch more – Momentum needed.
The entire Covid-19 booster program in the U. S. UU. no has been a resounding success. Only about 111. 3 million people in the U. S. U. S. citizens have gained at least one mRNA booster from Covid-19. Considering the United States has a population of about 329. 5 million, that’s less than 35% of the overall population. Only about 26. 7 million people ended up receiving the original Covid-19 mRNA booster of the moment. And only 19. 4 million (less than 6% of the general population) have gained Covid-19. 19 bivalent mRNA booster, as of October 21 according to CDC Covid data tracker. Since immune coverage opposite Covid-19 mRNA vaccines appears to be declining after 4 to six months, this means that the vast majority of the U. S. is still declining. The U. S. may also now place itself in a “declining world. “They may be less opposed to covid-19. Think about it the next time you wander through a large crowd without a mask to head to the typical plateau of nachos.
However, this modified EUA still does not allow the Novavax Covid-19 vaccine to serve as a booster for all situations. The FDA in particular legalizes the Novavax Covid-19 vaccine, with adjuvant, as “a first booster dose (0. 5 ml) the following Americans at least 6 months after completion of vaccination number one with a legal or approved COVID-19 vaccine:
This means that the Novavax Covid-19 vaccine can be used heterologous (the booster is of another type of vaccine used for series one) and homologous (i. e. the types of vaccines are the same) reinforcement. The inclusion of any of the types of boosters is vital because those who have already been vaccinated, have won the Pfizer-BioNTech or Moderna Covid-19 mRNA vaccines because they were, you know, the main game in the city and the ones that received the most attention from the Trump administrations and then Biden.
However, this leaves a major void in the EUA of the Novavax Covid-19 vaccine. The EUA specifies its use as a “booster first dose,” which technically does not come with those who have already gained at least one mRNA from Covid-19. booster. Some on social media wondered why:
The question is when the FDA will further expand the EUA to include all possible recall situations. USA Nuvaxovid will come with reinforcements. So now the wait begins for the next extension of the EUA. What exactly does the FDA want if the Novavax Covid-19 vaccine can serve as a momentary booster or the role that bivalent Covid-19 mRNA boosters are meant to play right now?And will such an expansion of the EUA take place before the next Covid-19 surge, which many expect to have in November?
It’s never a smart scenario for the U. S. U. S. Relying only on products from one or two pharmaceutical corporations as the U. S. did. This may make Biden’s management too dependent on Pfizer and Moderna and give those corporations too much bargaining power. Instead, Biden’s management deserves to continue to inspire the progression of new Covid-19 vaccine boosters and give all those boosters the same amount of time. First on the market does not necessarily mean the only one on the market. Otherwise, everyone would keep talking through Friendster, checking their schedules on their Palm Pilots, playing Everquest until four a. m. and watching the “Three Amigos” on Betamax than seeing Elon Musk tweeting about other “Three Amigos”.
Full coronavirus policy and updates